List of Excipients in API PYRAZINAMIDE
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing PYRAZINAMIDE
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Hikma Pharmaceuticals USA Inc | pyrazinamide | 0054-0812 | CELLULOSE, MICROCRYSTALLINE |
| Hikma Pharmaceuticals USA Inc | pyrazinamide | 0054-0812 | CROSCARMELLOSE SODIUM |
| Hikma Pharmaceuticals USA Inc | pyrazinamide | 0054-0812 | DIBASIC CALCIUM PHOSPHATE DIHYDRATE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for PYRAZINAMIDE
Excipient focus: CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
PYRAZINAMIDE drug variants containing CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Department of State Health Services Pharmacy Branch | pyrazinamide | 55695-026 |
| >Company | >Ingredient | >NDC |
PYRAZINAMIDE drug variants not containing CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | pyrazinamide | 0054-0812 |
| Major Pharmaceuticals | pyrazinamide | 0904-6696 |
| Macleods Pharmaceuticals Limited | pyrazinamide | 33342-447 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
PYRAZINAMIDE drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | pyrazinamide | 0054-0812 |
| A-S Medication Solutions | pyrazinamide | 50090-0520 |
| Department of State Health Services Pharmacy Branch | pyrazinamide | 55695-026 |
| >Company | >Ingredient | >NDC |
PYRAZINAMIDE drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | pyrazinamide | 0904-6696 |
| Macleods Pharmaceuticals Limited | pyrazinamide | 33342-447 |
| A-S Medication Solutions | pyrazinamide | 50090-0521 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
PYRAZINAMIDE drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | pyrazinamide | 0054-0812 |
| A-S Medication Solutions | pyrazinamide | 50090-0520 |
| Department of State Health Services Pharmacy Branch | pyrazinamide | 55695-026 |
| >Company | >Ingredient | >NDC |
PYRAZINAMIDE drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | pyrazinamide | 0904-6696 |
| Macleods Pharmaceuticals Limited | pyrazinamide | 33342-447 |
| A-S Medication Solutions | pyrazinamide | 50090-0521 |
| >Company | >Ingredient | >NDC |
Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE
PYRAZINAMIDE drug variants containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | pyrazinamide | 0054-0812 |
| A-S Medication Solutions | pyrazinamide | 50090-0520 |
| Akorn | pyrazinamide | 61748-012 |
| >Company | >Ingredient | >NDC |
PYRAZINAMIDE drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | pyrazinamide | 0904-6696 |
| Macleods Pharmaceuticals Limited | pyrazinamide | 33342-447 |
| A-S Medication Solutions | pyrazinamide | 50090-0521 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
PYRAZINAMIDE drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | pyrazinamide | 0904-6696 |
| Macleods Pharmaceuticals Limited | pyrazinamide | 33342-447 |
| A-S Medication Solutions | pyrazinamide | 50090-0521 |
| >Company | >Ingredient | >NDC |
PYRAZINAMIDE drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | pyrazinamide | 0054-0812 |
| A-S Medication Solutions | pyrazinamide | 50090-0520 |
| Department of State Health Services Pharmacy Branch | pyrazinamide | 55695-026 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
PYRAZINAMIDE drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | pyrazinamide | 33342-447 |
| >Company | >Ingredient | >NDC |
PYRAZINAMIDE drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | pyrazinamide | 0054-0812 |
| Major Pharmaceuticals | pyrazinamide | 0904-6696 |
| A-S Medication Solutions | pyrazinamide | 50090-0520 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
PYRAZINAMIDE drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | pyrazinamide | 0054-0812 |
| Macleods Pharmaceuticals Limited | pyrazinamide | 33342-447 |
| A-S Medication Solutions | pyrazinamide | 50090-0520 |
| >Company | >Ingredient | >NDC |
PYRAZINAMIDE drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | pyrazinamide | 0904-6696 |
| A-S Medication Solutions | pyrazinamide | 50090-0521 |
| A-S Medication Solutions | pyrazinamide | 50090-5963 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
PYRAZINAMIDE drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | pyrazinamide | 33342-447 |
| >Company | >Ingredient | >NDC |
PYRAZINAMIDE drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | pyrazinamide | 0054-0812 |
| Major Pharmaceuticals | pyrazinamide | 0904-6696 |
| A-S Medication Solutions | pyrazinamide | 50090-0520 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
PYRAZINAMIDE drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | pyrazinamide | 0904-6696 |
| Macleods Pharmaceuticals Limited | pyrazinamide | 33342-447 |
| A-S Medication Solutions | pyrazinamide | 50090-0521 |
| >Company | >Ingredient | >NDC |
PYRAZINAMIDE drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | pyrazinamide | 0054-0812 |
| A-S Medication Solutions | pyrazinamide | 50090-0520 |
| Department of State Health Services Pharmacy Branch | pyrazinamide | 55695-026 |
| >Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
PYRAZINAMIDE drug variants containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | pyrazinamide | 0054-0812 |
| Major Pharmaceuticals | pyrazinamide | 0904-6696 |
| A-S Medication Solutions | pyrazinamide | 50090-0520 |
| >Company | >Ingredient | >NDC |
PYRAZINAMIDE drug variants not containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | pyrazinamide | 33342-447 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
PYRAZINAMIDE drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | pyrazinamide | 33342-447 |
| >Company | >Ingredient | >NDC |
PYRAZINAMIDE drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | pyrazinamide | 0054-0812 |
| Major Pharmaceuticals | pyrazinamide | 0904-6696 |
| A-S Medication Solutions | pyrazinamide | 50090-0520 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
